Login  |  Register
go Advanced Search

My Cart (0 items) Help

 

Canada (change)

   

HomeMedicine Hematology
 

Recent Progress in the Treatment of Acute Lymphoblastic Leukemia, An Issue of Hematology/Oncology Clinics of North America

Saunders Title
ISBN: 978-1-4377-1227-8

Add to Cart
Check Out

Recent Progress in the Treatment of Acute Lymphoblastic Leukemia, An Issue of Hematology/Oncology Clinics of North America

By Wendy Stock, MD and Meir Wetzler, MD

Copyright 2009
$117.99, Hardcover, Reference

A title in the The Clinics: Internal Medicine Series.

Availability:This title is currently out of stock. We will ship as soon as we receive our stock.

 


Description

Acute lymphoblastic leukemia (ALL) is the most common malignancy diagnosed in children, representing nearly one third of all pediatric cancers. The annual incidence of ALL is about 30 cases per million people, with a peak incidence in children aged 2-5 years. Although a few cases are associated with inherited genetic syndromes, the cause of ALL remains largely unknown. This issue presents articles that discuss current thinking on the diagnosis and treatment of the disease. Articles specifically emphasize molecular genetics, allogeneic stem cell transplantation, and treatments including, clofarabine, nelarabine, rituximab, and PegAsp.

Author Information

By Wendy Stock, MD and Meir Wetzler, MD

Sign up today

Free Shipping with Online Orders

Print this page